Ousia Pharma
Latest round
- Seed
Last raised
- May 2025
Total raised
- Undisclosed
Investors
- 1
About Ousia Pharma
Founded in 2022 and located in Copenhagen, Denmark, Ousia Pharma specializes in developing advanced therapies for cardiometabolic conditions. The company has completed 2 deals to date, with their most recent deal taking place on May 6, 2025.Ousia Pharma specializes in the development of novel peptide-drug conjugates aimed at treating cardiometabolic diseases. Their core product offerings utilize a targeting approach that delivers modulators of synaptic plasticity specifically to appetite control regions of the brain. This method addresses key metabolic disorders by enhancing the regulation of appetite and energy balance. Ousia Pharma's primary clientele includes healthcare providers and research institutions focused on metabolic health, with end users being patients suffering from various cardiometabolic conditions.Ousia Pharma's revenue model is based on strategic partnerships and collaborations within the biomedical sector. The firm engages in B2B transactions, working directly with healthcare organizations, research entities, and pharmaceutical companies interested in innovative therapies for metabolic diseases. Revenue is generated through licensing agreements, research collaborations, and potentially through the sale of their peptide-drug conjugates once they reach market readiness. Ousia Pharma plans to design and launch new products targeting cardiometabolic conditions, with specific release dates to be announced. Additionally, they are looking to expand into new markets, particularly in Europe and North America, by 2026.
Who invested in Ousia Pharma
1 investor across 1 round
See all investors in Ousia Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 6, 2025
Amount
Undisclosed
Investors
Questions about Ousia Pharma
Who invested in Ousia Pharma?
Ousia Pharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ousia Pharma raised?
Ousia Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ousia Pharma last raise money?
Ousia Pharma's most recent round on record is a Seed, in May 2025.
What does Ousia Pharma do?
Founded in 2022 and located in Copenhagen, Denmark, Ousia Pharma specializes in developing advanced therapies for cardiometabolic conditions.
Where is Ousia Pharma headquartered?
Ousia Pharma is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Ousia Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Ousia Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ousia Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.